The 21st Century Cures Act: Help or Hinder?
Will the 21st Century Cures Act Help or Hinder Secondary Use of Health Data?
The 21st Century Cures Act is proposed legislation that aims to accelerate the discovery, development and delivery of life-saving therapies for patients. The focus of this bill is not patient privacy, but it has privacy implications. Five provisions would impact existing HIPAA legislation covering the use and disclosure of protected health information (PHI). It is unclear whether these provisions will foster new research or, in fact, be a detriment to patient privacy.
The Act passed the House of Representatives and is now headed to the Senate. This bill will have significant impact on health research and patient privacy. There are some good things in the Act, such as pushes to improve research collaboration, modernize clinical trials, and increase funding for the National Institutes of Health (NIH) and Food and Drug Administration (FDA). There are also concerns for what these changes mean when it comes to the rigor and evidence requirements for the approval of drugs and medical devices. This bill also means changes to HIPAA that affect privacy and how patient information is shared.
This white paper is written to review the real implications of the Act and offer solid critique around what this means for HIPAA and HITECH.
Download Will the 21st Century Cures Act Help or Hinder Secondary Use of Health Data? by filling out the form today.
Don’t miss it: the companion webinar to this white paper, 21st Century Cures Act Implications for Privacy and Research, featuring Privacy Analytics Khaled El Emam and Kirk Nahra from Wiley Rein LLP.